ArticleAnnals of thoracic surgery short reports2025
Long-term Mechanical Durability of Inspiris RESILIA Surgical Aortic Valves.
Article in Annals of thoracic surgery short reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Early Outcomes of Real-World Aortic Valve Replacement With RESILIA Tissue in the Chinese Population.Clinical cardiology · 2026Article
- Propensity-adjusted 8-year outcomes following bioprosthetic aortic valve replacement: The influence of novel anticalcification technology.JTCVS open · 2026Article
- Bioinspired functional materials for biomedical applications.Frontiers in bioengineering and biotechnology · 2026Review
- The Next Chapter in TAVR: Innovations and the Road Ahead.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prolonged mechanical durability and hemodynamic characteristics after durability tests of surgical valves need to be studied. Inspiris RESILIA (Edwards Lifesciences), a relatively recent and novel surgical aortic valve, was evaluated after accelerated wear testing. Methods: Three 21-mm and 3 23-mm Inspiris valves were cycled in the durability tester for 2 billion cycles (equivalent to 50 years) and were compared with a control valve of respective size. All valves were subjected to analysis, including particle image velocimetry for downstream flow fields and Results: All tested valves met the International Standards Organization durability requirements. The mean effective orifice areas for the 21-mm Inspiris control and test valves were 1.82 cm Conclusions: Inspiris RESILIA surgical aortic valves demonstrated very good hemodynamic performance after an equivalent of 50 years of simulated in vitro durability. In the absence of biologic agents, the valves showed no signs of gross damage. The Inspiris RESILIA showed a performance similar to that of 1 billion cycled valves from our previous study.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.